State Street SPDR S&P Biotech ETF vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? State Street SPDR S&P Biotech ETF trades at $149.93 (market cap $10.11B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.61 (market cap $330.98M). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 30.5× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR S&P Biotech ETF for 37 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| XBI | XDTE | |
|---|---|---|
Market Cap | $10.11B | $330.98M |
Volume | 12,903,266 | 194,030 |
Sector | Broad Market / Factor | Income / Options Overlay |
52-Week High | $169.55 | $44.76 |
52-Week Low | $104.99 | $36.00 |
Typical Hold Time | 37 Days | 54 Days |
Signals from Pluang's Aura AI — not financial advice
XBI trades at $150.23, down 0.44% on the day, with a bearish technical signal driven by moving averages and oscillators. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than broader healthcare funds.
The outlook is mixed: strong sector tailwinds from innovation and consolidation support growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst sentiment is neutral with 100% hold ratings, suggesting cautious optimism amid technical bearishness.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →